InvestorsHub Logo
Followers 37
Posts 6024
Boards Moderated 1
Alias Born 08/07/2018

Re: None

Monday, 03/30/2020 10:56:49 PM

Monday, March 30, 2020 10:56:49 PM

Post# of 163979

Manufacturing, Distribution and Sales

Vystar will continue production of UV Flu product lines with BOI, a world-class manufacturer. Vystar anticipates it will take 45 days to complete manufacture of the next orders of air purifier units and another 45 days to relaunch sales with a new, more robust distribution model. Vystar plans to sell RxAir residential units via online and retail channels.

Vystar is assembling the distribution network to relaunch sales of UV400 and Rx3000 units to the healthcare and medical markets, which UV Flu had ceased due to sales force, distribution and cash flow constraints. Once production and sales are firmly re-established, Vystar expects that the air purification products will produce margins of approximately 75%.

https://www.globenewswire.com/news-release/2018/05/10/1500134/0/en/Vystar-Acquires-Assets-of-UV-Flu-Technologies.html






VYST
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VYST News